These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 20731423)

  • 1. Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding.
    Wang LS; Wu LC; Lu SY; Chang LL; Teng IT; Yang CM; Ho JA
    ACS Nano; 2010 Aug; 4(8):4371-9. PubMed ID: 20731423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
    Rosenholm JM; Sahlgren C; Lindén M
    Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses.
    He Q; Zhang J; Shi J; Zhu Z; Zhang L; Bu W; Guo L; Chen Y
    Biomaterials; 2010 Feb; 31(6):1085-92. PubMed ID: 19880176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
    Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
    Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles.
    Pan L; He Q; Liu J; Chen Y; Ma M; Zhang L; Shi J
    J Am Chem Soc; 2012 Apr; 134(13):5722-5. PubMed ID: 22420312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles.
    Tsai CH; Vivero-Escoto JL; Slowing II; Fang IJ; Trewyn BG; Lin VS
    Biomaterials; 2011 Sep; 32(26):6234-44. PubMed ID: 21684000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
    Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
    ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A magnetic, reversible pH-responsive nanogated ensemble based on Fe3O4 nanoparticles-capped mesoporous silica.
    Gan Q; Lu X; Yuan Y; Qian J; Zhou H; Lu X; Shi J; Liu C
    Biomaterials; 2011 Mar; 32(7):1932-42. PubMed ID: 21131045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery.
    Chen Z; Li Z; Lin Y; Yin M; Ren J; Qu X
    Chemistry; 2013 Jan; 19(5):1778-83. PubMed ID: 23303570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of size on the cellular endocytosis and controlled release of mesoporous silica nanoparticles for intracellular delivery.
    Gan Q; Dai D; Yuan Y; Qian J; Sha S; Shi J; Liu C
    Biomed Microdevices; 2012 Apr; 14(2):259-70. PubMed ID: 22124885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo.
    Huang X; Li L; Liu T; Hao N; Liu H; Chen D; Tang F
    ACS Nano; 2011 Jul; 5(7):5390-9. PubMed ID: 21634407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous silica nanoparticles in medicine--recent advances.
    Mamaeva V; Sahlgren C; Lindén M
    Adv Drug Deliv Rev; 2013 May; 65(5):689-702. PubMed ID: 22921598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous carbon@silicon-silica nanotheranostics for synchronous delivery of insoluble drugs and luminescence imaging.
    He Q; Ma M; Wei C; Shi J
    Biomaterials; 2012 Jun; 33(17):4392-402. PubMed ID: 22425026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted cargo delivery in senescent cells using capped mesoporous silica nanoparticles.
    Agostini A; Mondragón L; Bernardos A; Martínez-Máñez R; Marcos MD; Sancenón F; Soto J; Costero A; Manguan-García C; Perona R; Moreno-Torres M; Aparicio-Sanchis R; Murguía JR
    Angew Chem Int Ed Engl; 2012 Oct; 51(42):10556-60. PubMed ID: 22996839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells.
    Slowing I; Trewyn BG; Lin VS
    J Am Chem Soc; 2006 Nov; 128(46):14792-3. PubMed ID: 17105274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
    Zhao Y; Sun X; Zhang G; Trewyn BG; Slowing II; Lin VS
    ACS Nano; 2011 Feb; 5(2):1366-75. PubMed ID: 21294526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous silica nanoparticles as nanocarriers.
    Wu SH; Hung Y; Mou CY
    Chem Commun (Camb); 2011 Sep; 47(36):9972-85. PubMed ID: 21716992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere.
    Vivero-Escoto JL; Slowing II; Wu CW; Lin VS
    J Am Chem Soc; 2009 Mar; 131(10):3462-3. PubMed ID: 19275256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.